B. Oruçoğlu Et Al. , "Discovery of SARS-CoV-2 3CLpro Inhibitor by Drug Repurposing Approach Using Biosafe SARS-CoV-2 Replicon," 9th International BAU Drug Design Congress , vol.1, no.12, İstanbul, Turkey, pp.45, 2023
Oruçoğlu, B. Et Al. 2023. Discovery of SARS-CoV-2 3CLpro Inhibitor by Drug Repurposing Approach Using Biosafe SARS-CoV-2 Replicon. 9th International BAU Drug Design Congress , (İstanbul, Turkey), 45.
Oruçoğlu, B., Çetin, İ., Topçul, M. R., & Gül, Ş., (2023). Discovery of SARS-CoV-2 3CLpro Inhibitor by Drug Repurposing Approach Using Biosafe SARS-CoV-2 Replicon . 9th International BAU Drug Design Congress (pp.45). İstanbul, Turkey
Oruçoğlu, Betül Et Al. "Discovery of SARS-CoV-2 3CLpro Inhibitor by Drug Repurposing Approach Using Biosafe SARS-CoV-2 Replicon," 9th International BAU Drug Design Congress, İstanbul, Turkey, 2023
Oruçoğlu, Betül Et Al. "Discovery of SARS-CoV-2 3CLpro Inhibitor by Drug Repurposing Approach Using Biosafe SARS-CoV-2 Replicon." 9th International BAU Drug Design Congress , İstanbul, Turkey, pp.45, 2023
Oruçoğlu, B. Et Al. (2023) . "Discovery of SARS-CoV-2 3CLpro Inhibitor by Drug Repurposing Approach Using Biosafe SARS-CoV-2 Replicon." 9th International BAU Drug Design Congress , İstanbul, Turkey, p.45.
@conferencepaper{conferencepaper, author={Betül Oruçoğlu Et Al. }, title={Discovery of SARS-CoV-2 3CLpro Inhibitor by Drug Repurposing Approach Using Biosafe SARS-CoV-2 Replicon}, congress name={9th International BAU Drug Design Congress}, city={İstanbul}, country={Turkey}, year={2023}, pages={45} }